It has been a day for milestones on the S&P/ASX 200 index on Thursday.
In morning trade the benchmark index has continued its positive run and broken through the 7,000 points mark for the first time in its history.
At the time of writing the S&P/ASX 200 index is up 0.6% to 7,035.1 points.
This follows the signing of a landmark phase one trade deal between the United States and China.
What other milestones are being made on the ASX 200?
The positive investor sentiment reverberating through the market has led to a number of other milestones being made on Thursday.
Chief among them is the CSL Limited (ASX: CSL) share price. In early trade the biotherapeutics giant’s shares broke through the $300 mark for the first time.
CSL’s shares topped out at a record high of $300.58 before retreating slightly.
It has also been a positive day of trade for some of CSL’s healthcare peers.
Cochlear’s shares raced to a record of $239.99, ResMed’s shares have hit a record high of $23.19, and Sonic Healthcare’s shares are trading at an all-time high of $30.84.
Fellow healthcare favourite Ramsay Health Care Limited (ASX: RHC) is also on form. It has reached a 52-week high of $75.66 this morning.
But the gains have not been restricted to the healthcare sector. Even banking giant Commonwealth Bank of Australia (ASX: CBA) is getting in on the action.
The shares of Australia’s largest bank have climbed to a 52-week high of $84.36 on Thursday. It is joined by Macquarie Group Ltd (ASX: MQG), which has continued its positive run and hit a record high of $142.48.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, ResMed Inc., and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- 3 mid cap ASX shares to buy for strong potential returns – September 23, 2020 4:17pm
- Why the Data#3 (ASX:DTL) share price just stormed to a record high – September 23, 2020 3:54pm
- Where to invest $10,000 into ASX shares right now – September 23, 2020 3:26pm